CLNC yields 36.68% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, CLNC + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CLNC + JNJ for your $10,000?
Colony Credit Real Estate, Inc. operates as a real estate investment trust. The company is headquartered in Los Angeles, California. The company is focused on originating and acquiring a diversified portfolio of CRE debt and net lease real estate investments. Its diversified portfolio consists of senior mortgage loans, mezzanine loans, preferred equity, CRE debt securities and net leased properties. The company operates through four segments: Commercial Real Estate Debt, which is focused on originating, acquiring and asset managing CRE debt investments, including mortgage loans, subordinate interests and mezzanine loans, as well as preferred equity interests; Commercial Real Estate Equity, which is focused on the ownership in real estate and real estate assets, and Commercial Real Estate Securities, which is focused on investing in commercial mortgage-backed securities, unsecured REIT debt, collateralized debt obligation (CDO) notes and other securities.
Full CLNC Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.